(Q38549721)

4 September 2017

High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension (English)

1 reference

4 September 2017

0 references

7

Polak JM

1 reference

4 September 2017

Mason NA

1

1 reference

4 September 2017

Springall DR

2

1 reference

4 September 2017

Burke M

3

1 reference

4 September 2017

Pollock J

4

1 reference

4 September 2017

Mikhail G

5

1 reference

4 September 2017

Yacoub MH

6

1 reference

4 September 2017

1 July 1998

1 reference

4 September 2017

1 reference

4 September 2017

185

1 reference

4 September 2017

3

1 reference

4 September 2017

313-318

1 reference

Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension

4 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199807%29185%3A3%3C313%3A%3AAID-PATH93%3E3.0.CO%3B2-8

Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199807%29185%3A3%3C313%3A%3AAID-PATH93%3E3.0.CO%3B2-8

Impairment of endothelium-dependent pulmonary vasodilation in patients with primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199807%29185%3A3%3C313%3A%3AAID-PATH93%3E3.0.CO%3B2-8

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199807%29185%3A3%3C313%3A%3AAID-PATH93%3E3.0.CO%3B2-8

Immunological detection of nitric oxide synthase(s) in human tissues using heterologous antibodies suggesting different isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199807%29185%3A3%3C313%3A%3AAID-PATH93%3E3.0.CO%3B2-8

High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199807%29185%3A3%3C313%3A%3AAID-PATH93%3E3.0.CO%3B2-8

The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199807%29185%3A3%3C313%3A%3AAID-PATH93%3E3.0.CO%3B2-8

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199807%29185%3A3%3C313%3A%3AAID-PATH93%3E3.0.CO%3B2-8

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199807%29185%3A3%3C313%3A%3AAID-PATH93%3E3.0.CO%3B2-8

Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199807%29185%3A3%3C313%3A%3AAID-PATH93%3E3.0.CO%3B2-8

Plasma levels of thrombomodulin in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199807%29185%3A3%3C313%3A%3AAID-PATH93%3E3.0.CO%3B2-8

10.1002/(SICI)1096-9896(199807)185:3<313::AID-PATH93>3.0.CO;2-8

21 January 2018

Identifiers

DOI

1 reference

4 September 2017

1 reference